Skip to search formSkip to main contentSkip to account menu

ML3000

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
We synthesized and evaluated inhibitors for the microsomal prostaglandin E2 synthase-1 (mPGES-1), based on the arylpyrrolizine… 
Highly Cited
2008
Highly Cited
2008
The anti-inflammatory drug licofelone [=ML3000; 2-[6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl… 
2008
2008
Objective: To find previously unknown properties of ML3000, a competitive inhibitor of the cyclooxygenase and the lipoxygenase… 
Highly Cited
2004
Highly Cited
2004
Since the discovery of aspirin about one century ago, many non-steroidal anti-inflammatory drugs (NSAIDs) have been used for the… 
2004
2004
  • S. Laufer
  • InflammoPharmacology
  • 2004
  • Corpus ID: 25951492
NSAID management of the inflammatory process has focused on reducing the production of inflammatory prostaglandins by inhibiting… 
Highly Cited
2002
Highly Cited
2002
Abstract.Objective: We examined the effects of ML3000 and several non-steroidal antiinflammatory drugs (NSAIDs) on the synthesis… 
2002
2002
Abstract.Design: The studies reported were designed to evaluate the effects of ML3000 on platelet aggregation and platelet… 
2001
2001
OBJECTIVE To search for potential new therapies to inhibit the progression of joint destruction in patients with rheumatoid…